|
DE1249281B
(enExample)
|
1963-05-18 |
|
|
|
|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
|
DE2027645A1
(de)
|
1970-06-05 |
1971-12-09 |
Byk Gulden Lomberg Chemische Fa bnk GmbH, 7750 Konstanz |
Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
|
|
NL7204972A
(enExample)
|
1971-04-21 |
1972-10-24 |
|
|
|
US3897432A
(en)
|
1971-04-21 |
1975-07-29 |
Merck & Co Inc |
Substituted benzimidazole derivatives
|
|
CA1023287A
(en)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4195128A
(en)
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
|
DE2644265C2
(de)
|
1976-09-30 |
1983-02-10 |
Bayer Ag, 5090 Leverkusen |
Chinazoline
|
|
US4330440A
(en)
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
|
CA1093991A
(en)
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Enzyme immobilization with pullulan gel
|
|
US4183931A
(en)
|
1977-09-08 |
1980-01-15 |
Research Corporation |
2-Ketoalkyl-4(3H)-quinazolinones
|
|
US4229537A
(en)
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
|
DE2812635A1
(de)
|
1978-03-22 |
1979-09-27 |
Bayer Ag |
Heterocyclische verbindungen
|
|
JPS55118918A
(en)
|
1979-03-06 |
1980-09-12 |
Mitsubishi Electric Corp |
Production of quinazolone ring-containing epoxy resin
|
|
JPS55118917A
(en)
|
1979-03-06 |
1980-09-12 |
Mitsubishi Electric Corp |
Production of quinazolone ring-containing epoxy resin
|
|
US4289872A
(en)
|
1979-04-06 |
1981-09-15 |
Allied Corporation |
Macromolecular highly branched homogeneous compound based on lysine units
|
|
JPS6017375B2
(ja)
|
1979-06-20 |
1985-05-02 |
三菱電機株式会社 |
ポリアミド樹脂の製造方法
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
DE3675588D1
(de)
|
1985-06-19 |
1990-12-20 |
Ajinomoto Kk |
Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
USRE35862E
(en)
|
1986-08-18 |
1998-07-28 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents encapsulated with proteinoids
|
|
WO1988001213A1
(en)
|
1986-08-18 |
1988-02-25 |
Clinical Technologies Associates, Inc. |
Delivery systems for pharmacological agents
|
|
US6696250B1
(en)
|
1986-12-03 |
2004-02-24 |
Competitive Technologies, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
US5229490A
(en)
|
1987-05-06 |
1993-07-20 |
The Rockefeller University |
Multiple antigen peptide system
|
|
US5225347A
(en)
|
1989-09-25 |
1993-07-06 |
Innovir Laboratories, Inc. |
Therapeutic ribozyme compositions and expression vectors
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
FR2675803B1
(fr)
|
1991-04-25 |
1996-09-06 |
Genset Sa |
Oligonucleotides fermes, antisens et sens et leurs applications.
|
|
SG43072A1
(en)
|
1991-06-18 |
1997-10-17 |
American Home Prod |
Method of treating adult t-cell leukemia/lymphoma
|
|
ATE156158T1
(de)
|
1992-04-14 |
1997-08-15 |
Cornell Res Foundation Inc |
Makromoleküle auf basis von dendritischen polymeren und verfahren zur herstellung
|
|
US5658780A
(en)
|
1992-12-07 |
1997-08-19 |
Ribozyme Pharmaceuticals, Inc. |
Rel a targeted ribozymes
|
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
|
US5378725A
(en)
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
|
GB9404485D0
(en)
|
1994-03-09 |
1994-04-20 |
Cancer Res Campaign Tech |
Benzamide analogues
|
|
FI951367A7
(fi)
|
1994-03-28 |
1995-09-29 |
Japan Energy Corp |
Puriinijohdannaiset ja tulehdustautien tukahduttajat (suppressantit)
|
|
US5480906A
(en)
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
|
FI970588L
(fi)
|
1994-08-12 |
1997-04-11 |
Pro Neuron Inc |
Menetelmät verenmyrkytyksen tai tulehdussairauksien hoitamiseksi oksipuriininukleosideillä
|
|
US5561138A
(en)
|
1994-12-13 |
1996-10-01 |
American Home Products Corporation |
Method of treating anemia
|
|
US6043062A
(en)
|
1995-02-17 |
2000-03-28 |
The Regents Of The University Of California |
Constitutively active phosphatidylinositol 3-kinase and uses thereof
|
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
|
US5948664A
(en)
|
1996-02-29 |
1999-09-07 |
The Regents Of The University Of California |
PI 3-kinase polypeptides
|
|
ATE279947T1
(de)
|
1996-03-18 |
2004-11-15 |
Univ Texas |
Immunglobulinähnliche domäne mit erhöhten halbwertszeiten
|
|
PT901487E
(pt)
|
1996-05-15 |
2003-08-29 |
Pfizer |
4(3h)-quinazolinonas 2,3,6-trissubstituidas
|
|
GB9611460D0
(en)
|
1996-06-01 |
1996-08-07 |
Ludwig Inst Cancer Res |
Novel lipid kinase
|
|
US5858753A
(en)
|
1996-11-25 |
1999-01-12 |
Icos Corporation |
Lipid kinase
|
|
TW528755B
(en)
|
1996-12-24 |
2003-04-21 |
Glaxo Group Ltd |
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
|
|
DE69723869T2
(de)
|
1996-12-31 |
2004-04-22 |
Dr. Reddy's Laboratories Ltd. |
Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten
|
|
GB9702701D0
(en)
|
1997-02-01 |
1997-04-02 |
Univ Newcastle Ventures Ltd |
Quinazolinone compounds
|
|
ID22711A
(id)
|
1997-02-28 |
1999-12-09 |
Pfizer Prod Inc |
Atropisomer dari 3-aril-4(3h)-kinazolinon dan penggunaannya sebagai antagonis reseptor-ampa
|
|
ATE303997T1
(de)
|
1997-06-09 |
2005-09-15 |
Pfizer Prod Inc |
Chinazolin-4-on ampa antagonisten
|
|
WO1999001139A1
(en)
|
1997-07-03 |
1999-01-14 |
Thomas Jefferson University |
An improved method for design and selection of efficacious antisense oligonucleotides
|
|
IL125950A0
(en)
|
1997-09-05 |
1999-04-11 |
Pfizer Prod Inc |
Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
|
|
EP1044004A1
(en)
|
1998-01-08 |
2000-10-18 |
The University Of Virginia Patent Foundation |
A2a adenosine receptor agonists in combination with a type iv phosphodiesterase inhibitors
|
|
WO1999008501A2
(en)
|
1998-04-23 |
1999-02-25 |
Dr. Reddy's Research Foundation |
New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
US6048970A
(en)
|
1998-05-22 |
2000-04-11 |
Incyte Pharmaceuticals, Inc. |
Prostate growth-associated membrane proteins
|
|
US6100090A
(en)
|
1999-06-25 |
2000-08-08 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of PI3K p85 expression
|
|
US6046049A
(en)
|
1999-07-19 |
2000-04-04 |
Isis Pharmaceuticals Inc. |
Antisense modulation of PI3 kinase p110 delta expression
|
|
ES2263501T3
(es)
|
1999-10-27 |
2006-12-16 |
Cytokinetics, Inc. |
Procedimiento y composiciones que utilizan quinazolinonas.
|
|
SK9742002A3
(en)
|
2000-01-07 |
2003-02-04 |
Transform Pharmaceuticals Inc |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
EP1857443B1
(en)
|
2000-01-24 |
2012-03-28 |
AstraZeneca AB |
Therapeutic morpholino-substituted compounds
|
|
AU2972701A
(en)
|
2000-02-07 |
2001-08-14 |
Bristol Myers Squibb Co |
3-aminopyrazole inhibitors of cyclin dependent kinases
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
DK2223922T3
(en)
|
2000-04-25 |
2016-06-06 |
Icos Corp |
Inhibitors of HUMANPHOSPHATIDYL-inositol 3-KINASEDELTA
|
|
AU2003247483A1
(en)
|
2002-05-30 |
2003-12-31 |
The Children's Hospital Of Philadelphia |
Methods for treatment of acute lymphocytic leukemia
|
|
US20040092561A1
(en)
|
2002-11-07 |
2004-05-13 |
Thomas Ruckle |
Azolidinone-vinyl fused -benzene derivatives
|
|
EA011807B1
(ru)
|
2002-07-10 |
2009-06-30 |
Лаборатуар Сероно Са |
Азолидинонвинильные производные конденсированного бензола
|
|
GB0217777D0
(en)
|
2002-07-31 |
2002-09-11 |
Novartis Ag |
Organic compounds
|
|
US20040023390A1
(en)
|
2002-08-05 |
2004-02-05 |
Davidson Beverly L. |
SiRNA-mediated gene silencing with viral vectors
|
|
CA2400254A1
(en)
|
2002-09-19 |
2004-03-19 |
University Health Network |
Compositions and methods for treating heart disease
|
|
AU2003293310B2
(en)
|
2002-09-30 |
2010-04-01 |
Bayer Intellectual Property Gmbh |
Fused azole-pyrimidine derivatives
|
|
JP2006510661A
(ja)
|
2002-12-06 |
2006-03-30 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
Ｐｉ３ｋの阻害剤としてのベンズオキサジン−３−オン類及びその誘導体
|
|
AU2003303231A1
(en)
|
2002-12-20 |
2004-07-14 |
Warner-Lambert Company Llc |
Benzoxazines and derivatives thereof as inhibitors of pi3ks
|
|
JP2006523237A
(ja)
|
2003-04-03 |
2006-10-12 |
セマフォア ファーマシューティカルズ， インコーポレイテッド |
Ｐｉ−３キナーゼインヒビタープロドラッグ
|
|
US20040259926A1
(en)
|
2003-06-05 |
2004-12-23 |
Bruendl Michelle M. |
3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
|
|
WO2004108716A1
(en)
|
2003-06-05 |
2004-12-16 |
Warner-Lambert Company Llc |
3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
|
|
MXPA05013061A
(es)
|
2003-06-05 |
2006-03-02 |
Warner Lambert Co |
Benzotiofenos sustituidos con cicloalquilos y heterocicloalquilos como agentes terapeuticos.
|
|
MXPA05013210A
(es)
|
2003-06-05 |
2006-03-09 |
Warner Lambert Co |
Benzo[b]tiofenos cicloalquilsulfanil-sustituidos como agentes terapeuticos.
|
|
JP2006526608A
(ja)
|
2003-06-05 |
2006-11-24 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
Ｐｉ３ｋ活性を有する治療薬としてのテトラゾールベンゾフランカルボキシアミド
|
|
WO2004108708A1
(en)
|
2003-06-05 |
2004-12-16 |
Warner-Lambert Company Llc |
3-substituted indoles and derivatives thereof as therapeutic agents
|
|
US20050043239A1
(en)
|
2003-08-14 |
2005-02-24 |
Jason Douangpanya |
Methods of inhibiting immune responses stimulated by an endogenous factor
|
|
US20050054614A1
(en)
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
|
CA2552664A1
(en)
|
2004-01-08 |
2005-07-28 |
Michigan State University |
Methods for treating and preventing hypertension and hypertension-related disorders
|
|
WO2005112935A1
(en)
|
2004-05-13 |
2005-12-01 |
Vanderbilt University |
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
|
|
EP1761540B1
(en)
|
2004-05-13 |
2016-09-28 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
|
CA2567883A1
(en)
|
2004-05-25 |
2005-12-15 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic cells
|
|
WO2005120511A1
(en)
|
2004-06-04 |
2005-12-22 |
Icos Corporation |
Methods for treating mast cell disorders
|
|
WO2006089106A2
(en)
|
2005-02-17 |
2006-08-24 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
|
WO2009058361A1
(en)
|
2007-10-31 |
2009-05-07 |
Dynavax Technologies Corp. |
Inhibition of type i ifn production
|
|
KR20160091440A
(ko)
*
|
2008-11-13 |
2016-08-02 |
길리아드 칼리스토가 엘엘씨 |
혈액 종양에 대한 요법
|
|
EP2365810A2
(en)
|
2008-12-04 |
2011-09-21 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of cns disorders
|
|
ES2634492T3
(es)
|
2008-12-24 |
2017-09-28 |
Prana Biotechnology Ltd |
Compuestos de quinazolinona
|
|
CA2756347A1
(en)
|
2009-03-24 |
2010-09-30 |
Gilead Calistoga Llc |
Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
|
|
SG175259A1
(en)
|
2009-04-20 |
2011-11-28 |
Gilead Calistoga Llc |
Methods of treatment for solid tumors
|
|
WO2011032277A1
(en)
|
2009-09-18 |
2011-03-24 |
Boehringer Ingelheim International Gmbh |
Quinazolinone derivatives as viral polymerase inhibitors
|
|
JP2013528228A
(ja)
*
|
2010-06-11 |
2013-07-08 |
ギリアード カリストガ エルエルシー |
キナゾリノン化合物による選択した患者における血液系障害を処置する方法
|
|
WO2013082540A1
(en)
*
|
2011-12-02 |
2013-06-06 |
Gilead Calistoga Llc |
Compositions and methods of treating a proliferative disease with a quinazolinone derivative
|
|
EA025407B1
(ru)
|
2012-03-05 |
2016-12-30 |
Джилид Калистога Ллс |
Полиморфная форма i (s)-2-(1-(9h-пурин-6-иламино)пропил)-5-фтор-3-фенилхиназолин-4(3h)-она
|
|
WO2015095605A1
(en)
|
2013-12-20 |
2015-06-25 |
Gilead Calistoga Llc |
Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one
|